OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rituximab in immunobullous disorders during the COVID ‐19 pandemic: A systematic review of observational studies
Michael Kasperkiewicz, David T. Woodley
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Closed Access | Times Cited: 4
Michael Kasperkiewicz, David T. Woodley
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Closed Access | Times Cited: 4
Showing 4 citing articles:
COVID-19 and autoimmune bullous diseases: Lessons learned
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy
Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 934-944
Open Access | Times Cited: 5
Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 934-944
Open Access | Times Cited: 5
Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
Brandon Levian, Stefan Tukaj, David T. Woodley, et al.
JEADV Clinical Practice (2024)
Open Access
Brandon Levian, Stefan Tukaj, David T. Woodley, et al.
JEADV Clinical Practice (2024)
Open Access
Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19
Michael Kasperkiewicz, Stefan Tukaj
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Michael Kasperkiewicz, Stefan Tukaj
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
